Thrombocytopenia, the acquired immunodeficiency syndrome (AIDS), and zidovudine. 1988

P Viens, and A Thyss, and G Garnier, and P Ayela

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

P Viens, and A Thyss, and G Garnier, and P Ayela
November 1989, Annals of internal medicine,
P Viens, and A Thyss, and G Garnier, and P Ayela
February 1993, The Journal of allergy and clinical immunology,
P Viens, and A Thyss, and G Garnier, and P Ayela
February 1990, Annals of internal medicine,
P Viens, and A Thyss, and G Garnier, and P Ayela
February 1992, Oral surgery, oral medicine, and oral pathology,
P Viens, and A Thyss, and G Garnier, and P Ayela
September 1985, Fortschritte der Medizin,
P Viens, and A Thyss, and G Garnier, and P Ayela
May 1983, Nederlands tijdschrift voor geneeskunde,
P Viens, and A Thyss, and G Garnier, and P Ayela
January 1985, The Journal of clinical investigation,
P Viens, and A Thyss, and G Garnier, and P Ayela
May 1983, Nederlands tijdschrift voor geneeskunde,
P Viens, and A Thyss, and G Garnier, and P Ayela
January 1989, Minerva medica,
P Viens, and A Thyss, and G Garnier, and P Ayela
January 1986, Soins. Gynecologie, obstetrique, puericulture, pediatrie,
Copied contents to your clipboard!